1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Sofosbuvir + velpatasvir
Trade Name:
Epclusa
Manufacturer/Distributor:
Gilead Sciences Canada
www.gilead.ca
Classification:
Antiviral agent
ATC Class:
J05AX - other antivirals
Status:
active
Notice of Compliance (yyyy/mm/dd):
2016/07/11
Date Marketed in Canada (yyyy/mm/dd):
2016/07/11
Presentation:
Tablet: 400 mg sofosbuvir + 100 mg velpatasvir. DIN: 02456370
Comments:
Combination product for treatment of chronic hepatitis C infection in adults without cirrhosis or with compensated cirrhosis
AND in combination with ribavirin for the treatment of chronic hepatitis C virus (HCV) infection in adults with decompensated cirrhosis.
Back to:
Drug Product Listings 
